Antimitotic Agents: all 5,052 studies that test it
Page 26 of 51. Open to participants first (616), then studies with results posted, then the rest; newest registration first within each.
- M7824 and Eribulin Mesylate in Treating Patients With Metastatic Triple Negative Breast CancerTerminatedNCT03579472Phase 1
- Neoadjuvant Chemotherapy Followed by Preoperative Chemoradiation in Resectable Squamous-cell Esophageal CancerStatus unknownNCT03579004Phase 2
- The Safety,Efficacy of Anti-EGFR Humanized Monoclonal Antibody Combined With Chemotherapy in Advanced Solid Tumors.CompletedNCT03577704Phase 1/2
- Single-Center Study Evaluating Systemic Exposure and Safety of KX2-391 Ointment 1% on the Face or Balding Scalp in Subjects With Actinic KeratosisCompletedNCT03575780Phase 1
- A Study to Test Radium-223 With Docetaxel in Patients With Prostate CancerActive, not recruitingNCT03574571Phase 3
- Does Cediranib With Paclitaxel, or Cediranib and Olaparib, Treat Advanced Endometrial Cancer Better Than Paclitaxel?Status unknownNCT03570437Phase 2
- Phase I Study of the Combination of Anlotinib With Pemetrexed or DocetaxelStatus unknownNCT03566576Not applicable
- QUILT-3.072: NANT Hepatocellular Carcinoma (HCC) VaccineWithdrawnNCT03563170Phase 1/2
- QUILT-3.088: NANT Pancreatic Cancer VaccineWithdrawnNCT03563144Phase 2
- QUILT-3.057: NANT Neoadjuvant Triple- Negative Breast Cancer (TNBC) VaccineWithdrawnNCT03554109Phase 2
- A Study of Oraxol in Subjects With Cutaneous AngiosarcomaCompletedNCT03544567Phase 2
- Clinical Study on Drug Sensitivity Verification or Prediction of Therapy for Breast Cancer by Patient-Derived Organoid ModelStatus unknownNCT03544047Not applicable
- FID-007 in Treating Participants With Advanced Solid TumorsActive, not recruitingNCT03537690Phase 1
- RCHOP Chemoimmunotherapy Preceded BY BBB Permeabilization by t-NGR Necrosis FactorCompletedNCT03536039Phase 2
- Scheduling Nab-paclitaxel With GemcitabineCompletedNCT03529175Phase 2
- NAPAGE: NAb-PAclitaxel and GEmcitabine in Advanced Soft Tissue SarcomaTerminatedNCT03524898Phase 1/2
- Nogapendekin Alfa Inbakicept for Advanced Non-Small Cell Lung CancerTerminatedNCT03520686Phase 3
- EphB4-HSA Fusion Protein and Cytarabine /or Liposomal Vincristine in Patients With Recurrent or Refractory Acute LeukemiaTerminatedNCT03519984Phase 1
- Paclitaxel-Avelumab for AngiosarcomaStatus unknownNCT03512834Phase 2
- Immunotherapy in Combination With Chemoradiation in Patients With Advanced Solid TumorsCompletedNCT03509012Phase 1
- Nab-paclitaxel in Combination with Gemcitabine for Pediatric Relapsed and Refractory Solid TumorsCompletedNCT03507491Phase 1
- An Early Phase Study of Abraxane Combined With Phenelzine Sulfate in Patients With Metastatic or Advanced Breast CancerCompletedNCT03505528Phase 1
- Chemotherapy Before Surgery and Radiation Therapy or Surgery and Radiation Therapy Alone in Treating Patients With Nasal and Paranasal Sinus Cancer That Can Be Removed by SurgeryActive, not recruitingNCT03493425Phase 2
- Pembrolizumab and Paclitaxel in Hypermutated Breast CancerCompletedNCT03492918Phase 2
- Vinorelbine in Advanced BRAF-like Colon CancerCompletedNCT03482362Phase 2
- A Study of Intraperitoneal Paclitaxel in Combination With SOX Compared With SOX Alone in Gastric Cancer With Malignant AscitesStatus unknownNCT03475615Phase 3
- A Study of Glofitamab in Combination With Rituximab or Obinutuzumab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP), or Polatuzumab Vedotin Plus Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone (CHP) in Participants With Non-Hodgkin Lymphomas or With DLBCLCompletedNCT03467373Phase 1
- Pembrolizumab and Nab Paclitaxel in Patients With Metastatic Urothelial CarcinomaCompletedNCT03464734Phase 2
- A Study of BNC105P Combined With IbrutinibCompletedNCT03454165Phase 1
- Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer (PANDA)Active, not recruitingNCT03448835Phase 2
- Vinorelbine for Recurrent ALCL-2017CompletedNCT03443128Phase 2
- A Phase 1/2 Study of FS118 in Patients With Advanced MalignanciesTerminatedNCT03440437Phase 1/2
- Radiation-hormone and Docetaxel VS Radiation-hormone in Patients With High-Risk Localized Prostate CancerStatus unknownNCT03432780Phase 2
- Sapanisertib, Carboplatin, and Paclitaxel in Treating Patients With Recurrent or Refractory Malignant Solid TumorsCompletedNCT03430882Phase 1
- Durvalumab and Eribulin in Her2-negative Metastatic Breast Cancer and Recurrent Ovarian CancerCompletedNCT03430518Phase 1
- The Maintenance Regimen and Revised Regimen for Advanced Breast Cancer Survivors After First-line Salvage TherapyStatus unknownNCT03423849Phase 2/3
- Apatinib Plus Docetaxel in Advanced Non-squamous Non-small Cell Lung Cancer(NSCLC)Status unknownNCT03416231Phase 2
- Efficacy and Safety of Nab-Paclitaxel Plus S-1 in the First-line Treatment of Advanced Pancreatic CancerCompletedNCT03415802Phase 2
- A Pilot Study of Eribulin in Breast Cancer (BC) Patients With Brain Metastases Previously Treated With Anthracyclines and TaxanesStatus unknownNCT03412955Phase 2
- Study of SBP-101 Combined With Nab-Paclitaxel and Gemcitabine in Pancreatic CancerCompletedNCT03412799Phase 1
- Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 SignalingStatus unknownNCT03412643Phase 2
- Apatinib in Combination With Docetaxel for Patients With Advanced NSCLCStatus unknownNCT03411967Phase 2
- Pembrolizumab With Chemotherapy in Front Line Advanced Ovarian, Primary Peritoneal and Fallopian Tube CancerStatus unknownNCT03410784Phase 2
- The EPIC Trial The Elderly Patient Individualized Chemotherapy TrialStatus unknownNCT03402048Phase 3
- The Effect of Gemcitabine Plus Nab-paclitaxel as Secondary Chemotherapy in Advanced Pancreatic CancerStatus unknownNCT03401827Phase 4
- A Study of VB-111 With Paclitaxel vs Paclitaxel for Treatment of Recurrent Platinum-Resistant Ovarian Cancer (OVAL)CompletedNCT03398655Phase 3
- Vinorelbine for Recurrent ACLCCompletedNCT03397953Phase 2
- Dose-finding Study of Colchicine in Type 2 Diabetic Patients With Coronary Artery DiseaseCompletedNCT03376698Phase 2
- A Phase II Trial of Cisplatin-Docetaxel Induction Plus Concurrent 3-D Conformal Radiotherapy and Weekly ChemotherapyCompletedNCT03371550Phase 2
- CPI-613 and Docetaxel in Treating Patients With Stage IIIB or IV Non-small Cell Lung CancerWithdrawnNCT03370159Phase 1/2
- 12 weekS Adjuvant dOcetaxel Plus trastuzumaB in Patients With Small, Node-negative, HER2-positive Breast cancER (SOBER)TerminatedNCT03367676Phase 2
- Paclitaxel, Cisplatin,5-FU vs. Radiotherapy Plus Paclitaxel, Cisplatin as Preoperative Therapy for Locally Advanced ESCStatus unknownNCT03366883Phase 3
- Eribulin and Radiation Therapy in Treating Patients With Retroperitoneal Liposarcoma That Can Be Removed by SurgeryActive, not recruitingNCT03361436Phase 1
- Combination Nab-paclitaxel (N-P) and Nintedanib or N-P and Placebo in Relapsed NSCLC AdenocarcinomaWithdrawnNCT03361319Phase 1/2
- Mutation Scores and Differential Protein Evaluating Efficacy in Adjuvant Chemotherapy in HER2(-) Luminal B Breast CancerStatus unknownNCT03359694Phase 3
- Pathological Complete Response Rate in Locally Advanced Breast Cancer With FEC, EC-T, or TC as Neoadjuvant ChemotherapyStatus unknownNCT03349177Phase 2/3
- Clinical Study of Neoadjuvant Therapy With Apatinib and Paclitaxel in Local Advanced Triple-negative Breast CancerStatus unknownNCT03348098Phase 2
- Durvalumab (MEDI4736) in Frail and Elder Patients With Metastatic NSCLC (DURATION)CompletedNCT03345810Phase 2
- Toxicity & Pharmacokinetics of 2 & 3-weekly Docetaxel in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)WithdrawnNCT03343977Phase 1/2
- Study of Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive CytologyCompletedNCT03330028Phase 1
- Study of Paclitaxel in Combination With BOS172722 in Patients With Advanced Nonhaematologic MalignanciesCompletedNCT03328494Phase 1
- Radiotherapy With or Without Concurrent Chemotherapy for Extensive Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-03Status unknownNCT03328234Phase 3
- Tesetaxel Plus Reduced Dose of Capecitabine vs. Capecitabine in HER2 Negative, HR Positive, LA/MBCTerminatedNCT03326674Phase 3
- Oral Paclitaxel Efficacy Safety and PK in Recurrent and Metastatic Breast CancerCompletedNCT03326102Phase 2
- Receiving Modified Chemotherapy Followed With Radical Resection After Neoadjuvant ChemotherapyStatus unknownNCT03322969Phase 2
- Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer PatientsStatus unknownNCT03321188Phase 2
- Modern Immunotherapy in BCG-Unresponsive, BCG-Relapsing and High Risk BCG-Naive Non-Muscle Invasive Urothelial Carcinoma of the BladderActive, not recruitingNCT03317158Phase 1/2
- Study of Gemcitabine, Nab-paclitaxel, and Ficlatuzumab (AV-299) in Patients With Advanced Pancreatic CancerCompletedNCT03316599Phase 1
- Oral Paclitaxel Trial In Recurrent and Metastatic Breast Cancer As 1st Line TherapyActive, not recruitingNCT03315364Phase 2/3
- Radiotherapy With or Without Concurrent Chemotherapy for Limited Lymphatic Metastasis of Esophageal Cancer - 3JECROG P-02Status unknownNCT03308552Phase 3
- Stromal TARgeting for PAncreatic Cancer (STAR_PAC)CompletedNCT03307148Phase 1
- Optimal Sequencing of Treatment Options for Poor Risk mCRPC Previously Treated With DocetaxelCompletedNCT03295565Phase 2/3
- Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced NeutropeniaActive, not recruitingNCT03294577Phase 3
- Neoadjuvant Pembrolizumab(Pbr)/Nab-Paclitaxel Followed by Pbr/Epirubicin/Cyclophosphamide in TNBCCompletedNCT03289819Phase 2
- Second-line CM082 Combined With Paclitaxel For Patients With Advanced Gastric CancerStatus unknownNCT03286244Phase 1
- MCS110 Combined With Neoadjuvant Doxorubicin, Cyclophosphamide, and Weekly Paclitaxel in Patients With Hormone-Receptor Positive and HER2- Breast CancerWithdrawnNCT03285607Phase 1
- Clinical Study of Decitabine and Paclitaxel Combination TherapyStatus unknownNCT03282825Phase 1
- Phase 2 Trial of Gemcitabine vs S-1 vs Gemcitabine Plus Nab-paclitaxel as Adjuvant Chemotherapy of Post-operative Pancreatic Cancer PatientsStatus unknownNCT03278015Phase 2
- Trial of Nab-paclitaxel in Patients With Desmoid Tumors and Multiply Relapsed/Refractory Desmoplastic Small Round Cell Tumors and Ewing SarcomaCompletedNCT03275818Phase 2
- Research of Intensive Treatment in Hormone Receptor<10% and Human Epidermal Growth Factor Receptor-2 Negative Breast Cancer Patients With Positive Lymph Node Residual Disease After Neoadjuvant ChemotherapyStatus unknownNCT03270007Phase 4
- A Study to Compare Eribulin Mesylate + Pertuzumab + Trastuzumab With Paclitaxel or Docetaxel + Pertuzumab + TrastuzumabCompletedNCT03264547Phase 3
- Exploratory Study on the Paclitaxel + S-1 + Oxaliplatin (PSOX) for Locally Advanced or Advanced Gastric CancerStatus unknownNCT03263741Phase 2
- Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPCCompletedNCT03263650Phase 2
- Nab-Paclitaxel Versus Paclitaxel Plus Carboplatin in Advanced Squamous Cell Non Small Cell Lung CancerStatus unknownNCT03262948Phase 3
- Cabazitaxel Activity in Patients With Advanced AdrenoCortical-Carcinoma Progressing After Previous Chemotherapy LinesStatus unknownNCT03257891Phase 2
- Compare Apatinib Plus Chemotherapy Drug Versus Chemotherapy Drug as Second-line Treatment in NSCLCTerminatedNCT03256721Phase 2
- Phase I Study of the Combination of Apatinib and POFStatus unknownNCT03244774Phase 1
- PemVin vs Vin in Previously Treated Metastatic Breast CancerCompletedNCT03242616Phase 2
- Atezolizumab With or Without Eribulin Mesylate in Treating Patients With Recurrent Locally Advanced or Metastatic Urothelial CancerActive, not recruitingNCT03237780Phase 2
- Sequencing of Radium-223 and Docetaxel in Symptomatic Bone-only Metastatic Castration-resistant Prostate CancerActive, not recruitingNCT03230734Phase 2
- QUILT-3.055: A Study of Combination Immunotherapies in Patients Who Have Previously Received Treatment With Immune Checkpoint InhibitorsActive, not recruitingNCT03228667Phase 2
- A Phase III Study of Fruquintinib in Combination With Paclitaxel in Second Line Gastric Cancer(FRUTIGA)CompletedNCT03223376Phase 3
- Neoadjuvant Chemotherapy With a Combination of Pegylated Liposomal Doxorubicin (Caelyx®) and Paclitaxel in Breast CancerCompletedNCT03221881Not applicable
- Study of Nab-paclitaxel in Sensitive and Refractory Relapsed SCLCStatus unknownNCT03219762Phase 2
- The Effectiveness and Safety of Intravesical Docetaxel Instillation for Prevent Bladder RecurrenceStatus unknownNCT03209206Phase 2
- Study of E7389 Liposomal Formulation in Participants With Solid TumorActive, not recruitingNCT03207672Phase 1
- Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemia in Children and AdolescentsActive, not recruitingNCT03206671Phase 3
- QUILT-3.051: NANT Ovarian Cancer Vaccine: Combination Immunotherapy in Subjects With Epithelial Ovarian Cancer Who Have Progressed on or After Standard-of-care (SoC) TherapyWithdrawnNCT03197584Phase 1/2
- QUILT-3.048: NANT Urothelial Cancer Vaccine: Combination Immunotherapy in Subjects With Urothelial Cancer Who Have Progressed on or After Chemotherapy and PD-1/PD-L1 TherapyWithdrawnNCT03197571Phase 1/2
- Study of Crenolanib With Ramucirumab and Paclitaxel for Advanced Esophagogastric AdenocarcinomaCompletedNCT03193918Phase 1